Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.
Krueger WA, Bulitta J, Kinzig-Schippers M, Landersdorfer C, Holzgrabe U, Naber KG, Drusano GL, Sörgel F. Krueger WA, et al. Among authors: naber kg. Antimicrob Agents Chemother. 2005 May;49(5):1881-9. doi: 10.1128/AAC.49.5.1881-1889.2005. Antimicrob Agents Chemother. 2005. PMID: 15855510 Free PMC article. Clinical Trial.
Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM, Kinzig-Schippers M, Sörgel F, Weidner W, Naber KG. Wagenlehner FM, et al. Among authors: naber kg. Int J Antimicrob Agents. 2006 Dec;28(6):551-9. doi: 10.1016/j.ijantimicag.2006.07.026. Epub 2006 Nov 13. Int J Antimicrob Agents. 2006. PMID: 17101261 Clinical Trial.
Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Wagenlehner FM, Wydra S, Onda H, Kinzig-Schippers M, Sörgel F, Naber KG. Wagenlehner FM, et al. Among authors: naber kg. Antimicrob Agents Chemother. 2003 Dec;47(12):3789-94. doi: 10.1128/AAC.47.12.3789-3794.2003. Antimicrob Agents Chemother. 2003. PMID: 14638484 Free PMC article. Clinical Trial.
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Dalhoff A, Naber KG. Wagenlehner FM, et al. Among authors: naber kg. Int J Antimicrob Agents. 2006 Jan;27(1):7-14. doi: 10.1016/j.ijantimicag.2005.09.014. Epub 2005 Dec 15. Int J Antimicrob Agents. 2006. PMID: 16343856 Clinical Trial.
Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Naber KG. Wagenlehner FM, et al. Among authors: naber kg. Antimicrob Agents Chemother. 2006 Nov;50(11):3947-9. doi: 10.1128/AAC.00477-06. Epub 2006 Sep 18. Antimicrob Agents Chemother. 2006. PMID: 16982785 Free PMC article. Clinical Trial.
412 results